Random

FDA

NSAID Side Effects Lead To Stronger FDA Warnings

NSAID Side Effects Lead To Stronger FDA Warnings

FDA Backlog Keeps Generics From Coming To Market

FDA Backlog Keeps Generics From Coming To Market

Why Isn’t the FDA Tougher on Tainted Supplements?

Why Isn’t the FDA Tougher on Tainted Supplements?

FDA Finds Eye Injections Caused Vision Impairment

FDA Finds Eye Injections Caused Vision Impairment

FDA Approves Radicava, First New ALS Drug In More Than 2 Decades

FDA Approves Radicava, First New ALS Drug In More Than 2 Decades

Questions For FDA Commissioner Nominee

Questions For FDA Commissioner Nominee

Suzanne B. Robotti

Are Direct-To-Consumer Ads Portraying Drug Risks Effectively?

Are Direct-To-Consumer Ads Portraying Drug Risks Effectively?

Kratom

Quick Hits: Opioid and Benzodiazepine, Kratom Ban & More

Study Questions Safety of Silicone Breast Implants; FDA Disputes Findings

Study Questions Safety of Silicone Breast Implants

FDA

Dear FDA: Do More When Nuplazid Has Issue After FDA Approval

FDA Encouraging Industry to Make More Opioid Abuse Therapies

FDA Encouraging Industry to Make More Opioid Abuse Therapies

FDA Again Delays Rule on New Safety Warnings for Generic Labels

FDA Again Delays Rule on New Safety Warnings for Generic Labels

FDA Advisory Committee: Weighing Risks and Benefits of Opana ER

Weighing Risks and Benefits of Opana ER

Suzanne B. Robotti

FDA Drug Recalls and Warnings: Recalls for Glaucoma Eye Medications and Allergy Eye Drops

FDA Drug Interactions/Side Effects

FDA Drug Recalls and Warnings: Recalls for Glaucoma Eye Medications and Allergy Eye Drops

FDA Reiterates Warning Against Power Morcellation For Fibroids

FDA Reiterates Warning Against Power Morcellation For Fibroids

Cryotherapy Risks

Quick Hits: Cryotherapy Risks & More

Sarah Rosenthal

Time For The FDA To Get Tough On Off-Label Drug Promotion

Time For The FDA To Get Tough On Off-Label Drug Promotion

Restasis: When Advertising Outweighs Research and Common Sense

Healthy Skeptic 2

Restasis: When Advertising Outweighs Research and Common Sense

Suzanne B. Robotti

FDA: Why Drugs Should Take A Long Time To Get To Market

FDA: Why Drugs Should Take A Long Time To Get To Market

Suzanne B. Robotti

FDA

Rare Peek Into Internal FDA Furor: ARBs

Medshadow Staff

Load More

x

x